Cite
APA Citation
Ip, H. N. N., Hwang, I., Kang, J., Kim, K., Jeong, J. H., Chang, H., Ryoo, B., & Yoo, C. (n.d.). 193PPrognostic implication of inflammation-based scores in patients with metastatic pancreatic cancer (mPC) treated with first-line nab-paclitaxel plus gemcitabine (AG). Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095508155.0x000038